nitrosourea
{{Chembox
| ImageFileL1 = Nitrosourea.svg
| ImageFileL1_Ref = {{chemboximage|correct|??}}
| ImageSizeL1 = 121
| ImageNameL1 = Skeletal formula of a minor tautomer of nitrosourea
| ImageFileR1 = Nitrosourea-3D-balls.png
| ImageFileR1_Ref = {{chemboximage|correct|??}}
| ImageSizeR1 = 121
| ImageNameR1 = Ball and stick model a minor tautomer of nitrosourea
| IUPACName = Nitrosourea
| Section1 = {{Chembox Identifiers
| CASNo = 13010-20-3
| CASNo_Ref = {{cascite|correct|CAS}}
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = S0W1V6314Y
| PubChem = 105035
| ChemSpiderID = 94772
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| SMILES = NC(=O)N=NO
| SMILES1 = C(=O)(N)NN=O
| StdInChI = 1S/CH3N3O2/c2-1(5)3-4-6/h(H3,2,3,5,6)
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = OSTGTTZJOCZWJG-UHFFFAOYSA-N
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
}}
| Section2 = {{Chembox Properties
| C=1 | H=3 | N=3 | O=2
}}
}}
Nitrosourea is both the name of a molecule, and a class of compounds that include a nitroso (R-NO) group and a urea.
Examples
Examples include:
- Arabinopyranosyl-N-methyl-N-nitrosourea (Aranose)
- Carmustine (BCNU, BiCNU)
- Chlorozotocin
- Ethylnitrosourea (ENU)
- Fotemustine
- Lomustine (CCNU)
- Nimustine
- N-Nitroso-N-methylurea (NMU)
- Ranimustine (MCNU)
- Semustine
- Streptozocin (Streptozotocin)
Nitrosourea compounds are DNA alkylating agents and are often used in chemotherapy.{{cite web |url=http://faculty.swosu.edu/scott.long/phcl/antineop.htm |title=Antineop |access-date=2009-01-24 |url-status=dead |archive-url=https://web.archive.org/web/20090307052941/http://faculty.swosu.edu/scott.long/phcl/antineop.htm |archive-date=2009-03-07 }} They are lipophilic and thus can cross the blood–brain barrier, making them useful in the treatment of brain tumors such as glioblastoma multiforme.Takimoto CH, Calvo E. [http://www.cancernetwork.com/cancer-management-11/chapter03/article/10165/1402628 "Principles of oncologic pharmacotherapy".] in Pazdur R, Wagman LD, Camphausen KA, Hoskins WJ (Eds) [http://www.cancernetwork.com/cancer-management-11/ Cancer management: a multidisciplinary approach]. 11 ed. 2008.
File:Aranose (Haworth).svg|Arabinopyranosyl-N-methyl-N-nitrosourea
File:Carmustine.svg|Carmustine
File:Chlorozotocin (Haworth).svg|Chlorozotocin
File:ENU.svg|Ethylnitrosourea
File:Fotemustine.svg|Fotemustine
File:Lomustine.svg|Lomustine
File:N-Nitroso-N-methylurea.svg|N-Nitroso-N-methylurea
File:Nimustine.svg|Nimustine
File:Ranimustine (Haworth).svg|Ranimustine
File:Semustine.svg|Semustine
File:Streptozocin (Haworth).svg|Streptozocin
Side effects
Some nitrosoureas (e.g. lomustine) have been associated with the development of interstitial lung disease.{{cite journal |vauthors=Tucci E, Verdiani P, Di Carlo S, Sforza V |title=Lomustine (CCNU)-induced pulmonary fibrosis |journal=Tumori |volume=72 |issue=1 |pages=95–8 |year=1986 |doi=10.1177/030089168607200114 |pmid=3952821|s2cid=33327504 }}
References
{{Reflist}}
External links
- {{MeshName|Nitrosourea+Compounds}}
- {{DiseasesDB|9052}}
{{Chemotherapeutic agents}}
{{Inorganic-compound-stub}}
{{Organic-compound-stub}}